The FDA and a $1.2 billion startup are analyzing how drugs are used after approval — and it could one day change… https://t.co/DncCyXQT5l

The FDA and a $1.2 billion startup are analyzing how drugs are used after approval — and it could one day change… https://t.co/DncCyXQT5l

— The Propell Group (@ThePropellGroup) June 3, 2017

#healthtech